News
Two NIH Technology Transfer experts will be speaking at the Biotechnology Innovation Organization 2025 International Convention taking place in Boston, June 16-19, 2025, with pre-conference sessions taking place June 14-15. Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer

Six NIH technologies that have been developed into commercial products are featured in Federal Technology Transfer 2006, a new booklet from the Federal Laboratory Consortium (FLC). The booklet is a compilation of some of the most promising projects from FLC's member laboratories and agencies during

Tuberculosis (TB) is a disease of mammoth proportions both in human lives lost and economic impact. Although preventative measures in this country have left the US relatively unscathed, TB is the second leading cause of death in adults worldwide. It disproportionately affects populations with poorer

Neglected diseases affect approximately 1 billion people, primarily in developing countries. However, since most R&D is not focused on neglected diseases, very few new treatments are brought to market. Through its partnerships with international public and private institutions, the NIH Office of